deltatrials
Completed PHASE4 INTERVENTIONAL 3-arm NCT03915964

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis

Sponsor: Eli Lilly and Company

Conditions Rheumatoid Arthritis
Interventions Baricitinib TNF Inhibitor
Updated 37 times since 2019 Last updated: Jul 21, 2025 Started: Apr 25, 2019 Primary completion: May 28, 2025 Completion: May 28, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Rheumatoid Arthritis, this trial is completed. The trial is conducted by Eli Lilly and Company and has accumulated 37 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jul 2022 · 10 months · monthly snapshot~Jul 2022 – ~Apr 2023 · 9 months · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Apr 2024 · 11 months · monthly snapshot~Apr 2024 – ~May 2024 · 30 days · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Jan 2025 · 3 months · monthly snapshot~Jan 2025 – ~Feb 2025 · 31 days · monthly snapshot~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshot~Mar 2025 – ~May 2025 · 2 months · monthly snapshot~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – ~Aug 2025 · 2 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 8 months · monthly snapshot

Change History

37 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Aug 2025 — Sep 2025 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

  3. Jun 2025 — Aug 2025 [monthly]

    Active Not Recruiting PHASE4

  4. May 2025 — Jun 2025 [monthly]

    Active Not Recruiting PHASE4

  5. Mar 2025 — May 2025 [monthly]

    Active Not Recruiting PHASE4

▶ Show 32 earlier versions

  1. Feb 2025 — Mar 2025 [monthly]

    Active Not Recruiting PHASE4

  2. Jan 2025 — Feb 2025 [monthly]

    Active Not Recruiting PHASE4

  3. Oct 2024 — Jan 2025 [monthly]

    Active Not Recruiting PHASE4

  4. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting PHASE4

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE4

  6. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE4

  7. May 2024 — Jun 2024 [monthly]

    Active Not Recruiting PHASE4

  8. Apr 2024 — May 2024 [monthly]

    Active Not Recruiting PHASE4

  9. May 2023 — Apr 2024 [monthly]

    Active Not Recruiting PHASE4

  10. Apr 2023 — May 2023 [monthly]

    Active Not Recruiting PHASE4

  11. Jul 2022 — Apr 2023 [monthly]

    Active Not Recruiting PHASE4

  12. Sep 2021 — Jul 2022 [monthly]

    Active Not Recruiting PHASE4

  13. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE4

  14. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

  15. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE4

  16. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE4

  17. Sep 2020 — Oct 2020 [monthly]

    Recruiting PHASE4

  18. Aug 2020 — Sep 2020 [monthly]

    Recruiting PHASE4

  19. Jul 2020 — Aug 2020 [monthly]

    Recruiting PHASE4

    Status: Suspended → Recruiting

  20. May 2020 — Jul 2020 [monthly]

    Suspended PHASE4

    Status: Recruiting → Suspended

  21. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE4

  22. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE4

  23. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE4

  24. Jan 2020 — Feb 2020 [monthly]

    Recruiting PHASE4

  25. Dec 2019 — Jan 2020 [monthly]

    Recruiting PHASE4

  26. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE4

  27. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE4

  28. Sep 2019 — Oct 2019 [monthly]

    Recruiting PHASE4

  29. Aug 2019 — Sep 2019 [monthly]

    Recruiting PHASE4

  30. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE4

  31. Jun 2019 — Jul 2019 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  32. May 2019 — Jun 2019 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eli Lilly and Company
  • Incyte Corporation
Data source: Eli Lilly and Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Albuquerque, United States , Alexanroupolis, Greece , Ashkelon, Israel , Atlanta, United States , Bad Doberan, Germany , Baia Mare, Romania , Barcelona, Spain , Basel, Switzerland , Baytown, United States and 206 more locations